Editorial Note: This post follows on from one of the most compelling RxISK stories ever – Abilify, Tourette Syndrome and Me, posted last week. It comes in two parts. The first by last week’s author and the second by the series editor, Johanna Ryan. In our efforts to get our story told, raise awareness about […]
Read more ....
Editorial Note: This post is by DG. It’s number three in the Abilify series, following Dodging Abilify and Abilify from the Inside Out. I was diagnosed with Tourette Syndrome (TS) as a child. It was always manageable. I did well in school and was actively involved with music programs at church and school. At 17, […]
Read more ....
Editorial Note: This is part 2 of Johanna Ryan’s series that started with Dodging Abilify. Abilify is at present the best-selling drug in North America – how come? In last week’s column, Dodging Abilify, I described the fan-club enthusiasm for this drug among doctors I’ve met, my own reluctance to try it, and what I’d […]
Read more ....
Editorial Note: This post is by Johanna Ryan, who has a unique ability to capture the American Nightmare. The best-selling drug in the United States isn’t a blood pressure pill, a painkiller or even an antidepressant. It’s Abilify, an antipsychotic agent with $6.3 billion in 2013 sales. Granted, Abilify isn’t the most prescribed pill, but […]
Read more ....
Editorial Note: This post continues from last week’s Persecution of Heretics. It’s about how only a Popular Movement with those suffering adverse effects on drugs speaking up can save us now. It adapts a talk given a month ago to the International Society for Ethical Psychology and Psychiatry in Los Angeles. It loses something without […]
Read more ....
Editorial Note: This extraordinary account of what it can be like to live on psychotropic drugs came by email out of the blue from Jim Seko. For the record, it looks from here that Jim cannot have had schizophrenia. His original problem almost has to be an acute and transient psychosis. The tragedy of these […]
Read more ....
Editorial Note: Courtesy of Fast Forward, here is a 12 month follow up to Olanzapine Withdrawal: Sally’s Story; some good, some OK and some awful. Sounds and speech Twelve months later, I continue to have problems with my hearing. The serious sensitivity to sounds has settled a bit – so I don’t jump out of my […]
Read more ....
Editorial Note: How long does withdrawal last? How much overlap is there between antipsychotic, benzodiazepine and antidepressant withdrawal? This is the first of two posts covering these issues. All answers later this week in part two. For Antipsychotic Withdrawal – see also Carole’s Story. I was prescribed olanzapine 20 mg in 2001, as a mood […]
Read more ....
Editorial Note: This is a brief synopsis of Dear Luise by Dorrit Cato Christensen – a story of power and powerlessness, and a most extraordinary book. Extraordinary because of the horror it outlines. Extraordinary because of Dorrit’s restraint when writing about her daughter. Do things go as badly wrong as this often – yes. Are we doing anything to stop disasters like […]
Read more ....
The last post outlined the horrors of dopamine agonist withdrawal syndrome (DAWS). This week’s features the equally grim horror of dopamine antagonist withdrawal syndrome (DAAWS). The dopamine antagonists include the antipsychotic, anti-nausea, anti-itch and other groups of drugs. The antipsychotics were the first of the modern psychotropic drugs to be linked to severe withdrawal, but […]
Read more ....
Blog categories
Media
Newsletter
Follow us
